✦ LIBER ✦

2107 POSTER Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer

✍ Scribed by M. Kozloff; E. Chuang; J. Roy; A. Starr; P.A. Gowland; M.J. Tarpey; M. Collier; L. Verkh; K. Kern; K. Miller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib Plus Paclitaxel Versus Bevaciz

✍ Nicholas J. Robert; Mansoor N. Saleh; Devchand Paul; Daniele Generali; Laurent G 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 798 KB

3542 POSTER Preliminary results from a p

✍ Y. Bang; Y. Kang; W. Kang; N. Boku; H. Chung; J. Tursi; M.J. Lechuga; L. Verkh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Capecitabine plus paclitaxel versus epir

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

A phase II trial of paclitaxel (Taxol®)

✍ Sandra M. Swain; Susan F. Honig; Mariella C. Tefft; Linda Walton 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 467 KB

Mitoxantrone as first line cytotoxic the

✍ Mouridsen, H.T.; Rose, C.; Nooy, M.A.; van Oosterom, A.T. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 325 KB

A phase I study of imexon plus gemcitabi

✍ Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 275 KB